Malignant mesothelioma—the UK experience
In Britain it is estimated that the annual number of mesothelioma deaths will rise from approximately 1500 in the year 2000 to a peak of approximately 3000 in 2020. A database on the natural history of mesothelioma has provided a baseline for a new trial at The Royal Marsden looking at early versus...
Saved in:
Published in | Lung cancer (Amsterdam, Netherlands) Vol. 45; pp. S133 - S135 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
Shannon
Elsevier Ireland Ltd
01.08.2004
Elsevier Science |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | In Britain it is estimated that the annual number of mesothelioma deaths will rise from approximately 1500 in the year 2000 to a peak of approximately 3000 in 2020. A database on the natural history of mesothelioma has provided a baseline for a new trial at The Royal Marsden looking at early versus delayed chemotherapy in mesothelioma as a new approach to treatment. In the UK chemotherapy is usually in the form of MVP (mitomycin, vinblastine and cisplatin) or vinorelbine, and data have been collected from trials covering both regimens. There is now a national working group for mesothelioma (BMIG) and a proposal for a national trial is being taken forward, comparing chemotherapy with MVP or single agent vinorelbine in addition to active symptom control (ASC) with ASC alone. Novel agents are also being investigated and SRL172 has shown some benefits in combination with chemotherapy in the treatment of malignant mesothelioma. |
---|---|
AbstractList | In Britain it is estimated that the annual number of mesothelioma deaths will rise from approximately 1500 in the year 2000 to a peak of approximately 3000 in 2020. A database on the natural history of mesothelioma has provided a baseline for a new trial at The Royal Marsden looking at early versus delayed chemotherapy in mesothelioma as a new approach to treatment. In the UK chemotherapy is usually in the form of MVP (mitomycin, vinblastine and cisplatin) or vinorelbine, and data have been collected from trials covering both regimens. There is now a national working group for mesothelioma (BMIG) and a proposal for a national trial is being taken forward, comparing chemotherapy with MVP or single agent vinorelbine in addition to active symptom control (ASC) with ASC alone. Novel agents are also being investigated and SRL172 has shown some benefits in combination with chemotherapy in the treatment of malignant mesothelioma. |
Author | O’Brien, Mary E.R |
Author_xml | – sequence: 1 givenname: Mary E.R surname: O’Brien fullname: O’Brien, Mary E.R email: maryo@icr.ac.uk organization: Royal Marsden NHS Trust, Royal Marsden Hospital and Kent Cancer Centre, Downs Road, Sutton, Surrey SM2 5PT, UK |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15953822$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/15261447$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkM1Kw0AQgBep2FZ9BKUXPQip-5tNTiLFP6x4sedls5nULcmm7iaiNx_CJ_RJTG1Ab8LADMw3P3xjNHC1A4SOCJ4STOLz1bRs3dJoN6UY8-kmKN9BI5JIGiWM0QEadVwaCYzpEI1DWGFMJMHpHhoSQWPCuRyhswdd2qXTrplUEOrmGUpbV_rr47MrJ4v7CbytwVtwBg7QbqHLAId93keL66un2W00f7y5m13OI8NS0kSmoFqQhMcFZASD1IlOGMmFzjPJci5SKdNcyESyohBpnOGuywQxmZSEcpKxfXS63bv29UsLoVGVDQbKUjuo26DiWFIsOe5AsQWNr0PwUKi1t5X274pgtZGkVqqXpDaS1CYo7-aO-wNtVkH-O9Vb6YCTHtDB6LLw2hkb_nCpYAmlHXex5aDT8WrBq2B-VOXWg2lUXtt_XvkGzsmIwA |
CODEN | LUCAE5 |
CitedBy_id | crossref_primary_10_1093_annonc_mdj073 crossref_primary_10_1158_1535_7163_MCT_06_0073 |
Cites_doi | 10.1054/bjoc.2000.1401 10.1038/sj.bjc.6600063 10.1016/S0140-6736(95)92542-2 10.1016/S0140-6736(95)90462-X 10.1200/JCO.2000.18.23.3912 10.1136/thorax.55.9.731 10.1023/A:1008236010868 |
ContentType | Journal Article |
Copyright | 2004 Elsevier Ireland Ltd 2004 INIST-CNRS |
Copyright_xml | – notice: 2004 Elsevier Ireland Ltd – notice: 2004 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.lungcan.2004.04.024 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1872-8332 |
EndPage | S135 |
ExternalDocumentID | 10_1016_j_lungcan_2004_04_024 15261447 15953822 S0169500204001850 |
Genre | Journal Article Review |
GeographicLocations | United Kingdom Europe |
GroupedDBID | --- --K --M .1- .55 .FO .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29L 4.4 457 4CK 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO ABBQC ABFNM ABGSF ABJNI ABLJU ABLVK ABMAC ABMZM ABUDA ABXDB ABYKQ ACDAQ ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEHWI AEKER AENEX AEVXI AFCTW AFKWA AFRHN AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AHPSJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DOVZS DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HED HMK HMO HVGLF HZ~ IHE J1W KOM LCYCR M29 M41 MO0 N9A O-L O9- OAUVE OC~ OO- OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SEL SES SEW SPCBC SSH SSU SSZ T5K UDS WUQ X7M Z5R ZGI ~G- AAPBV AAUGY ABPIF IQODW AAXKI AFJKZ AKRWK CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c391t-cf2a51846feb10e7a8a831d5adb73d459779d57873ff596b0831351cb771241b3 |
IEDL.DBID | .~1 |
ISSN | 0169-5002 |
IngestDate | Fri Aug 16 22:31:55 EDT 2024 Thu Sep 26 19:17:52 EDT 2024 Sat Sep 28 07:40:40 EDT 2024 Sun Oct 22 16:04:26 EDT 2023 Fri Feb 23 02:33:49 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | MVP (mitomycin, vinblastine and cisplatin) Active symptom control Natural history of mesothelioma SRL172 Vinorelbine Antineoplastic agent Lung disease Mitomycin Vinblastine Respiratory disease Malignant tumor History Natural Bronchopulmonary malignant tumor Cisplatin vinblastine and cisplatin); Vinorelbine; Active symptom control; SRL172 Symptomatology Malignant mesothelioma Natural history of mesothelioma; MVP (mitomycin Bronchus disease Active control |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c391t-cf2a51846feb10e7a8a831d5adb73d459779d57873ff596b0831351cb771241b3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
PMID | 15261447 |
PQID | 66720740 |
PQPubID | 23479 |
ParticipantIDs | proquest_miscellaneous_66720740 crossref_primary_10_1016_j_lungcan_2004_04_024 pubmed_primary_15261447 pascalfrancis_primary_15953822 elsevier_sciencedirect_doi_10_1016_j_lungcan_2004_04_024 |
PublicationCentury | 2000 |
PublicationDate | 2004-08-01 |
PublicationDateYYYYMMDD | 2004-08-01 |
PublicationDate_xml | – month: 08 year: 2004 text: 2004-08-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Shannon |
PublicationPlace_xml | – name: Shannon – name: Ireland |
PublicationTitle | Lung cancer (Amsterdam, Netherlands) |
PublicationTitleAlternate | Lung Cancer |
PublicationYear | 2004 |
Publisher | Elsevier Ireland Ltd Elsevier Science |
Publisher_xml | – name: Elsevier Ireland Ltd – name: Elsevier Science |
References | Peto, Hodgson, Matthews, Jones (BIB1) 1995; 345 Grange, Stanford, Rook (BIB5) 1995; 345 Assersohn, Souberbielle, O’Brien, Archer, Mendes, Bass (BIB7) 2000; 83 O’Brien, Saini, Smith, Webb, Gregory, Mendes (BIB6) 2000; 83 Edwards, Abrams, Leverment, Spyt, Waller, O’Byrne (BIB2) 2000; 55 Steele, Shamash, Evans, Gower, Tischkowitz, Rudd (BIB4) 2000; 18 Middleton, Smith, O’Brien, Norton, Hickish, Priest (BIB3) 1998; 9 Mendes, O’Brien, Mitra, Norton, Gregory, Padhani (BIB8) 2002; 86 Middleton (10.1016/j.lungcan.2004.04.024_BIB3) 1998; 9 Edwards (10.1016/j.lungcan.2004.04.024_BIB2) 2000; 55 O’Brien (10.1016/j.lungcan.2004.04.024_BIB6) 2000; 83 Peto (10.1016/j.lungcan.2004.04.024_BIB1) 1995; 345 Steele (10.1016/j.lungcan.2004.04.024_BIB4) 2000; 18 Assersohn (10.1016/j.lungcan.2004.04.024_BIB7) 2000; 83 Grange (10.1016/j.lungcan.2004.04.024_BIB5) 1995; 345 Mendes (10.1016/j.lungcan.2004.04.024_BIB8) 2002; 86 |
References_xml | – volume: 83 start-page: 43 year: 2000 ident: BIB7 article-title: A randomised pilot study of SRL172 ( publication-title: Br. J. Cancer contributor: fullname: Bass – volume: 55 start-page: 731 year: 2000 end-page: 735 ident: BIB2 article-title: Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems publication-title: Thorax contributor: fullname: O’Byrne – volume: 18 start-page: 3912 year: 2000 end-page: 3917 ident: BIB4 article-title: Phase II study of vinorelbine in patients with malignant pleural mesothelioma publication-title: J. Clin. Oncol. contributor: fullname: Rudd – volume: 86 start-page: 336 year: 2002 end-page: 341 ident: BIB8 article-title: Clinical and immunological assessment of publication-title: Br. J. Cancer contributor: fullname: Padhani – volume: 83 start-page: 853 year: 2000 end-page: 857 ident: BIB6 article-title: A pilot randomised study of SRL172 combined with chemotherapy in patients with advanced inoperable non-small cell lung cancer and mesothelioma publication-title: Br. J. Cancer contributor: fullname: Mendes – volume: 345 start-page: 535 year: 1995 end-page: 539 ident: BIB1 article-title: Continuing increase in mesothelioma mortality in Britain publication-title: Lancet contributor: fullname: Jones – volume: 9 start-page: 269 year: 1998 end-page: 273 ident: BIB3 article-title: Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma publication-title: Ann. Oncol. contributor: fullname: Priest – volume: 345 start-page: 1350 year: 1995 end-page: 1352 ident: BIB5 article-title: Tuberculosis and cancer: parallels in host responses and therapeutic approaches? publication-title: Lancet contributor: fullname: Rook – volume: 83 start-page: 853 year: 2000 ident: 10.1016/j.lungcan.2004.04.024_BIB6 article-title: A pilot randomised study of SRL172 combined with chemotherapy in patients with advanced inoperable non-small cell lung cancer and mesothelioma publication-title: Br. J. Cancer doi: 10.1054/bjoc.2000.1401 contributor: fullname: O’Brien – volume: 83 start-page: 43 issue: Suppl 1 year: 2000 ident: 10.1016/j.lungcan.2004.04.024_BIB7 article-title: A randomised pilot study of SRL172 (Mycobacterium vaccae) in patients with small cell lung cancer (SCLC) treated with chemotherapy publication-title: Br. J. Cancer contributor: fullname: Assersohn – volume: 86 start-page: 336 issue: 3 year: 2002 ident: 10.1016/j.lungcan.2004.04.024_BIB8 article-title: Clinical and immunological assessment of Mycobacterium vaccae (SRL172) with chemotherapy in patients with malignant mesothelioma publication-title: Br. J. Cancer doi: 10.1038/sj.bjc.6600063 contributor: fullname: Mendes – volume: 345 start-page: 1350 year: 1995 ident: 10.1016/j.lungcan.2004.04.024_BIB5 article-title: Tuberculosis and cancer: parallels in host responses and therapeutic approaches? publication-title: Lancet doi: 10.1016/S0140-6736(95)92542-2 contributor: fullname: Grange – volume: 345 start-page: 535 year: 1995 ident: 10.1016/j.lungcan.2004.04.024_BIB1 article-title: Continuing increase in mesothelioma mortality in Britain publication-title: Lancet doi: 10.1016/S0140-6736(95)90462-X contributor: fullname: Peto – volume: 18 start-page: 3912 year: 2000 ident: 10.1016/j.lungcan.2004.04.024_BIB4 article-title: Phase II study of vinorelbine in patients with malignant pleural mesothelioma publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2000.18.23.3912 contributor: fullname: Steele – volume: 55 start-page: 731 year: 2000 ident: 10.1016/j.lungcan.2004.04.024_BIB2 article-title: Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems publication-title: Thorax doi: 10.1136/thorax.55.9.731 contributor: fullname: Edwards – volume: 9 start-page: 269 year: 1998 ident: 10.1016/j.lungcan.2004.04.024_BIB3 article-title: Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma publication-title: Ann. Oncol. doi: 10.1023/A:1008236010868 contributor: fullname: Middleton |
SSID | ssj0017109 |
Score | 1.7799041 |
SecondaryResourceType | review_article |
Snippet | In Britain it is estimated that the annual number of mesothelioma deaths will rise from approximately 1500 in the year 2000 to a peak of approximately 3000 in... |
SourceID | proquest crossref pubmed pascalfrancis elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | S133 |
SubjectTerms | Active symptom control Antineoplastic Agents, Phytogenic - therapeutic use Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Cisplatin - administration & dosage Clinical Trials as Topic Humans Medical sciences Mesothelioma - drug therapy Mesothelioma - pathology Mitomycins - administration & dosage MVP (mitomycin, vinblastine and cisplatin) Natural history of mesothelioma Pneumology SRL172 Tumors of the respiratory system and mediastinum United Kingdom Vinblastine - administration & dosage Vinblastine - analogs & derivatives Vinblastine - therapeutic use Vinorelbine |
Title | Malignant mesothelioma—the UK experience |
URI | https://dx.doi.org/10.1016/j.lungcan.2004.04.024 https://www.ncbi.nlm.nih.gov/pubmed/15261447 https://search.proquest.com/docview/66720740 |
Volume | 45 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEF5KBRFEfBsfNQdPQppmH0n2WIqlWtqLFnoLm2QjlTYttr2KP8Jf6C9xJo_WHoog5BBClmy-3Xmx38wQchdL5mghhCWZG1lcQszqK82sCEyPjiAkkRIThXt9tzPgT0MxrJBWmQuDtMpC9-c6PdPWxRO7QNOejUb2M9YREVlyJ3aWy-J2DsYI9nT9Y0XzcJBrmNf3lha-vc7isd_qYxAo-IMsTMwqnlK-zT7tz9QcUEvydhfb_dHMLrUPyUHhUJrNfM5HpKLTY7LbK47MT8h9DzztV6S7mBM9x3yr8Wg6Ud-fX3BrDrqmXhU7PiWD9sNLq2MVDRKsiElnYUUJVQJCNDcBjdvQnvKVz5xYqDj0WMyxtJyMUSRZkgjphthVjAknCj0PzLoTsjNSTaepvkCGk9BxQ2cizXlC_chTiUp45FBXhrFjkHoJSzDL62AEJUHsLShwxJ6WPMCLcoP4JXjBxoIGoKv_GlrbAHv9QSFBP1NqkNsS_QCkAY84VKqny3nguh4Fp6hhkPN8UX6NpRj7epf_n9cV2ct5O0j_uybVxftS34BLsghr2Z6rkZ3mY7fT_wGrUN6X |
link.rule.ids | 315,786,790,4521,24144,27957,27958,45620,45714 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LasJAFB3EQlsope-mD82iq0LUzCPJLIu02GrcVMHdMEkmRdEoVbelH9Ev7Jd0bh5aF1IoZBFChsycyX0x596L0F3Eia0YYxYnTmhRrmNWTypihdr0qFCHJJxDorDfdVp9-jJggxJqFrkwQKvMdX-m01NtnT-p52jWZ8Nh_RXqiLA0uRM6y0HcvgPuPPRvqH2seB42kA2zAt_cgtfXaTz1UW2sJUovIY0T05KnmG4zUAczOdewxVm_i-0OaWqYno7QYe5Rmg_ZpI9RSSUnaNfPz8xP0b2vXe034LuYEzWHhKvxcDqR359f-tbst021qnZ8hvpPj71my8o7JFgh4fbCCmMsmY7RnFir3IZypSc9YkdMRoFLIgq15XgEMknimHEngLZihNlh4LrartsBOUflZJqoS6A4MRU1VCrTlMbYC10Zy5iGNnZ4ENkGqhWwiFlWCEMUDLGRyHGEppZUwIWpgbwCPLGxo0Ir67-GVjbAXn-Qca2gMTZQtUBfaHGAMw6ZqOlyLhzHxdorahjoItuUX2MxBL_u1f_nVUV7rZ7fEZ3nbvsa7WckHuAC3qDy4n2pbrV_sggq6f_3A-c-4Ck |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Malignant+mesothelioma%E2%80%94the+UK+experience&rft.jtitle=Lung+cancer+%28Amsterdam%2C+Netherlands%29&rft.au=O%E2%80%99Brien%2C+Mary+E.R&rft.date=2004-08-01&rft.issn=0169-5002&rft.volume=45&rft.spage=S133&rft.epage=S135&rft_id=info:doi/10.1016%2Fj.lungcan.2004.04.024&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_lungcan_2004_04_024 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0169-5002&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0169-5002&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0169-5002&client=summon |